Healthcare - Biotechnology - NASDAQ - US
$ 3.345
-6.95 %
$ 439 M
Market Cap
-1.54
P/E
Price Target
Average
378.33%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
20.04%
Net Income
Estimate
14.03%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Prime Medicine, Inc.
Wall Street analysts predict an average 1-year price target for PRME of $16 , with forecasts ranging from a low of $12 to a high of $23 .
PRME Lowest Price Target
Wall Street Target
12 USD
258.74%
PRME Average Price Target
Wall Street Target
16 USD
378.33%
PRME Highest Price Target
Wall Street Target
23 USD
587.59%
REVENUE FORECAST
Revenue Forecast Chart PRME
EBIT FORECAST
EBIT Forecast Chart PRME
NET INCOME FORECAST
Net Income Chart PRME